Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial (Q37065849)
Jump to navigation
Jump to search
scientific article published on 06 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial |
scientific article published on 06 May 2013 |
Statements
1 reference
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial (English)
1 reference
Amylou C Dueck
1 reference
Edith A Perez
1 reference
George W Sledge
1 reference
Wilma L Lingle
1 reference
Ann E McCullough
1 reference
Beiyun Chen
1 reference
Xochiquetzal J Geiger
1 reference
Robert B Jenkins
1 reference
Nancy E Davidson
1 reference
Silvana Martino
1 reference
Peter A Kaufman
1 reference
Leila A Kutteh
1 reference
Lyndsay N Harris
1 reference
Julie R Gralow
1 reference
Monica M Reinholz
1 reference
6 May 2013
1 reference
1 reference
2115-2122
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference